Lactobacillus

Pronunciation: lak-toh-buh-SIL-us.

Generic name
Lactobacillus (a genus of lactic-acid-producing probiotic bacteria; common species include L. acidophilus, L. rhamnosus, L. reuteri, L. casei, L. plantarum, and others)
Drug class
Not applicable in most markets -- Lactobacillus is a probiotic dietary/food supplement ingredient, not a regulated drug class, except for two specific Health-Canada-licensed strains described below
Form
Capsule, tablet, powder, or incorporated into food/beverage products, depending on the specific product
Route
Oral
Legal status
Varies by country: dietary/food supplement (US, UK, EU, New Zealand), self-certified Listed complementary medicine (Australia), or licensed Natural Health Product (Canada) -- see country-by-country detail

Supply Rules Vary

Trade names by country: United States · United Kingdom · Canada · Australia · New Zealand

Australia: METAGENICS ULTRAFLORA LGG PROBIOTIC (illustrative real example) (9), Multi-strain probiotic (illustrative real example, JSHealth Vitamins) (9) · Full directory

What Lactobacillus (a genus of lactic-acid-producing probiotic bacteria; common species include L. acidophilus, L. rhamnosus, L. reuteri, L. casei, L. plantarum, and others) is and how it works

Lactobacillus is a genus of bacteria naturally found in the human gut and in fermented foods, used as a 'probiotic' -- a live microorganism intended to provide a health benefit when taken in adequate amounts. It is sold as a dietary/food supplement (or, in Canada, as a licensed Natural Health Product) rather than as a single approved drug. (1) (2) (3)

Because Lactobacillus products are regulated very differently around the world -- as a food supplement in most of the markets reviewed, but as a licensed health product with specific permitted claims for two particular strains in Canada -- what a product is legally allowed to say about it varies by country. No Lactobacillus product reviewed here is an approved treatment for a disease in the United States, United Kingdom, European Union, or New Zealand sources reviewed. People with a weakened immune system, serious illness, or a central venous catheter should talk to a clinician before using any probiotic, because of a real, documented (though rare) risk of bloodstream infection in those groups.

Mechanism of action: how Lactobacillus (a genus of lactic-acid-producing probiotic bacteria; common species include L. acidophilus, L. rhamnosus, L. reuteri, L. casei, L. plantarum, and others) works

Lactobacillus species are lactic-acid-producing bacteria that colonise the gut and are thought to exert probiotic effects through mechanisms including competitive exclusion of pathogens, modulation of the intestinal barrier and immune response, and production of short-chain fatty acids and other metabolites; specific mechanisms and evidence strength vary considerably by strain, which is why regulators generally require strain-specific rather than genus-wide evidence for any claim. (3) (7)

What Lactobacillus (a genus of lactic-acid-producing probiotic bacteria; common species include L. acidophilus, L. rhamnosus, L. reuteri, L. casei, L. plantarum, and others) is used for

General digestive/gut-health support (most markets)

In the United States, United Kingdom, European Union, and New Zealand, Lactobacillus products are sold as dietary/food supplements that may describe a general effect on digestive or gut health (a 'structure/function' claim in the US), but may not claim to treat, cure, or prevent any disease. (2) (4) (5) (10)

Antibiotic-associated and acute infectious diarrhoea (Canada, Lactobacillus rhamnosus GG specifically)

In Canada specifically, Health Canada's Natural Health Product monograph permits products containing the strain Lactobacillus rhamnosus GG to state that they 'help to manage acute infectious diarrhoea' and 'help to manage/reduce the risk of antibiotic-associated diarrhoea'. This permitted claim applies only to this named strain and only in Canada. (7)

Adjunct to H. pylori antibiotic therapy (Canada, Lactobacillus johnsonii La1 specifically)

In Canada specifically, Health Canada's monograph permits products containing the strain Lactobacillus johnsonii La1 (Lj1/NCC 533) to be described as 'an adjunct to physician-supervised antibiotic therapy in patients with Helicobacter pylori infections'. This permitted claim applies only to this named strain and only in Canada, and only alongside physician-directed antibiotic treatment, not as a replacement for it. (7)

Before taking Lactobacillus (a genus of lactic-acid-producing probiotic bacteria; common species include L. acidophilus, L. rhamnosus, L. reuteri, L. casei, L. plantarum, and others)

Do not take / not appropriate for

  • Do not use any probiotic, including Lactobacillus products, as a substitute for a prescribed antibiotic or other physician-directed treatment for an infection. (all countries) (7)
  • If you are immunocompromised, critically ill, or have a central venous catheter, do not start a probiotic without first checking with your clinician, given documented (though rare) cases of probiotic-associated bloodstream infection in these groups. (all countries) (3)

Tell your clinician about

  • Whether you are immunocompromised (e.g. chemotherapy, transplant, advanced HIV/AIDS), critically ill, or have a central venous catheter -- this changes the risk/benefit balance for any probiotic.
  • Any other supplements or medicines you take, and any digestive condition you have.
  • Whether you are pregnant or breastfeeding.
  • Which specific product and strain you are considering -- since permitted claims and evidence genuinely differ by strain and by country.
(3) (7)

How to take Lactobacillus (a genus of lactic-acid-producing probiotic bacteria; common species include L. acidophilus, L. rhamnosus, L. reuteri, L. casei, L. plantarum, and others)

  • Follow the specific product's label instructions -- dose, colony-forming-unit (CFU) count, and timing vary widely between different Lactobacillus-containing products, and there is no single universal dose for 'Lactobacillus' as a genus.
  • Discuss the specific strain and product with a pharmacist, dietitian, or clinician if you are using it for a particular health goal, especially in Canada where only certain strains carry specific permitted claims.
(1)

Procedures and treatment changes

Tell the treating team before surgery, procedures, or any medicine change. Do not alter treatment without the responsible clinician. (1) (2) (3) (4) (5) (6) (7) (8) (9) (10)

Missed dose

Because Lactobacillus is a supplement rather than a scheduled medicine with a therapeutic blood level to maintain, simply resume your normal routine at the next planned dose. If you are using it under a clinician's specific direction (for example, alongside antibiotic therapy in Canada), check with them if you are unsure how to proceed.

Overdose

Lactobacillus supplements are generally well tolerated in healthy people, and serious harm from taking too much is not described in the sources reviewed. If you experience severe digestive symptoms, fever, or any new symptoms suggestive of infection (especially if you are immunocompromised, critically ill, or have a central venous catheter), contact a clinician promptly. (3)

Side effects

Side effects and their urgency vary; report severe, persistent, or concerning symptoms.

Mild digestive symptoms such as bloating, gas, or an upset stomach, especially when first starting.

What to notice: Mild digestive symptoms such as bloating, gas, or an upset stomach, especially when first starting.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)

Reported adverse event

Incidence: See prescribing information

Serious warnings

Signs of bloodstream infection (bacteraemia/fungaemia) in immunocompromised, critically ill, or central-venous-catheter patients — high caution

Symptoms: Fever, chills, low blood pressure, or feeling generally unwell, particularly around a catheter site.

Action: This is a rare but real, documented safety signal in the sources reviewed. If you are immunocompromised, critically ill, or have a central line and develop these symptoms while using a probiotic, contact a clinician or emergency service promptly for assessment. (3)

Signs of a serious allergic reaction — emergency

Symptoms: Swelling of the face, lips, tongue, or throat; difficulty breathing; widespread rash or hives.

Action: Seek emergency medical help immediately. (1)

Interactions

  • No major drug interactions are described for Lactobacillus generally in the sources reviewed, though timing relative to antibiotics is sometimes recommended by product labels (to protect the live organisms) -- check the specific product's instructions. (7)
  • Do not rely on a probiotic to replace or reduce a prescribed antibiotic course -- in Canada, the permitted claim for L. johnsonii La1 is specifically as an adjunct alongside physician-supervised antibiotic therapy, not a substitute for it. (7)

Pregnancy, breastfeeding, kidney/liver function, age

Pregnancy

Specific pregnancy safety data were not detailed in the sources reviewed for this dossier; discuss any probiotic use with your clinician or midwife during pregnancy. (1) (2) (3) (4) (5) (6) (7) (8) (9) (10)

Breastfeeding

Specific breastfeeding safety data were not detailed in the sources reviewed for this dossier; discuss with your clinician. (1) (2) (3) (4) (5) (6) (7) (8) (9) (10)

Children

Use in children should follow product-specific labelling and, where relevant, a paediatrician's guidance -- general paediatric dosing was not detailed in the sources reviewed. (1) (2) (3) (4) (5) (6) (7) (8) (9) (10)

Immunocompromised_or_critically_ill

This is the population with the clearest documented safety signal in the sources reviewed: rare cases of probiotic-associated bacteraemia/fungaemia, particularly with a central venous catheter present. Clinical guidance referenced in the sources specifically advises against Saccharomyces boulardii use in immunocompromised, critically ill, or central-venous-catheter patients; the same caution is extended here to live-organism probiotics generally pending individual clinical assessment. (1) (2) (3) (4) (5) (6) (7) (8) (9) (10)

Monitoring

Before starting

  • Discussion with a clinician if immunocompromised, critically ill, or if you have a central venous catheter
  • Confirmation of the specific strain and product, since permitted claims and evidence differ by strain

During treatment

  • Watch for digestive symptoms and, in at-risk groups, any sign of infection (fever, chills, feeling unwell).
(3)

Storage

Follow the specific product's storage instructions -- many probiotic products require refrigeration to keep the live organisms viable, while others are shelf-stable; check the product label.

Professional information

Clinician/dietitian-facing context only, sourced from the NIH ODS probiotics fact sheet, CDC safety literature, and the Health Canada NHP monograph; verify against current product-specific labelling before recommending.

United States / United Kingdom / European Union / New Zealand

Indication: General digestive/gut-health support (structure/function claim only; no disease-treatment claim permitted)

Dose summary: No single standardised dose; varies by product and CFU count.

Renal context: Not specifically addressed in the sources reviewed. (2) (4) (5) (10)

Canada

Indication: Licensed Natural Health Product; general probiotic claims for most strains, plus specific claims for L. rhamnosus GG (infectious/antibiotic-associated diarrhoea) and L. johnsonii La1 (H. pylori antibiotic-therapy adjunct)

Dose summary: Per the specific licensed NHP's approved label (NPN); varies by strain and product.

Renal context: Not specifically addressed in the sources reviewed. (7)

Australia

Indication: Listed complementary medicine (AUST L); sponsor-self-certified indications

Dose summary: Per the specific ARTG-listed product's label; varies by product.

Renal context: Not specifically addressed in the sources reviewed. (8) (9)

Mechanism of action

Hepatic guidance

Not specifically addressed in the sources reviewed.

Overdose note

No specific antidote; serious probiotic-related adverse events are rare and concentrated in immunocompromised/critically ill/central-line populations, where the response is supportive care and, if infection is suspected, prompt clinical assessment and, where relevant, catheter management. (3) (7)

Frequently asked questions

Is Lactobacillus a medicine or a supplement?

It depends on the country and the specific product. In the United States, United Kingdom, European Union, and New Zealand, Lactobacillus is sold as a dietary/food supplement, and products cannot legally claim to treat or prevent disease. In Australia, it is regulated as a self-certified 'Listed' complementary medicine. In Canada, it is licensed as a Natural Health Product, and two specific strains (L. rhamnosus GG and L. johnsonii La1) carry Health-Canada-permitted claims that go beyond general wellness wording. (2) (4) (8) (7) (10)

Can Lactobacillus treat diarrhoea?

This depends on the strain and country. In Canada specifically, products containing the strain Lactobacillus rhamnosus GG are permitted by Health Canada to state they help manage acute infectious diarrhoea and antibiotic-associated diarrhoea. In the US, UK, EU, and New Zealand sources reviewed, general Lactobacillus products cannot legally make a disease-treatment claim like this -- always check what a specific product is actually permitted to say in your country. (7)

Is it safe for everyone to take a Lactobacillus probiotic?

Most healthy people tolerate probiotics well, with mild digestive symptoms being the main common effect. However, there is a real, documented (though rare) risk of bloodstream infection in people who are immunocompromised, critically ill, or have a central venous catheter. If this applies to you, talk to a clinician before starting any probiotic. (3)

What is the mechanism of action of Lactobacillus (a genus of lactic-acid-producing probiotic bacteria; common species include L. acidophilus, L. rhamnosus, L. reuteri, L. casei, L. plantarum, and others)?

Lactobacillus species are lactic-acid-producing bacteria that colonise the gut and are thought to exert probiotic effects through mechanisms including competitive exclusion of pathogens, modulation of the intestinal barrier and immune response, and production of short-chain fatty acids and other metabolites; specific mechanisms and evidence strength vary considerably by strain, which is why regulators generally require strain-specific rather than genus-wide evidence for any claim. (3) (7)

What is the generic name of Lactobacillus?

The generic name is Lactobacillus (a genus of lactic-acid-producing probiotic bacteria; common species include L. acidophilus, L. rhamnosus, L. reuteri, L. casei, L. plantarum, and others). (1) (2)

What class of drug is Lactobacillus (a genus of lactic-acid-producing probiotic bacteria; common species include L. acidophilus, L. rhamnosus, L. reuteri, L. casei, L. plantarum, and others)?

Lactobacillus is classed as: Not applicable in most markets -- Lactobacillus is a probiotic dietary/food supplement ingredient, not a regulated drug class, except for two specific Health-Canada-licensed strains described below. (1) (2)

References

  1. Probiotics -- Fact Sheet for Health ProfessionalsNational Institutes of Health, Office of Dietary Supplements · United States · accessed 2026-07-30 · source 1
  2. Structure/Function Claims (dietary supplement labeling)U.S. Food and Drug Administration · United States · accessed 2026-07-30 · source 2
  3. Regulatory Oversight and Safety of Probiotic UseCenters for Disease Control and Prevention, Emerging Infectious Diseases journal · United States · accessed 2026-07-30 · source 3
  4. Guidance Note 8: A Guide to What is a Medicinal Product (borderline products guidance)Medicines and Healthcare products Regulatory Agency · United Kingdom · dated 2025-10-17 · accessed 2026-07-30 · source 4
  5. EFSA opinions on health claims related to bacterial strains / probioticsEuropean Food Safety Authority · European Union · accessed 2026-07-30 · source 5
  6. EU Novel Food Catalogue update -- 34 probiotic strains assigned 'not novel' statusEuropean Commission · European Union · dated 2025-12-19 · accessed 2026-07-30 · source 6
  7. Natural Health Product Monograph -- ProbioticsHealth Canada, Natural and Non-prescription Health Products Directorate · Canada · accessed 2026-07-30 · source 7
  8. Australian Regulatory Guidelines for Listed Medicines (ARGLM)Therapeutic Goods Administration · Australia · accessed 2026-07-30 · source 8
  9. Example real ARTG-listed Lactobacillus-containing probiotic products (illustrative, not exhaustive)Therapeutic Goods Administration · Australia · dated 2025-04-09 · accessed 2026-07-30 · source 9
  10. Regulation of Dietary SupplementsMedsafe (New Zealand Medicines and Medical Devices Safety Authority) · New Zealand · accessed 2026-07-30 · source 10

Brand names by country

Single-ingredient Lactobacillus (a genus of lactic-acid-producing probiotic bacteria; common species include L. acidophilus, L. rhamnosus, L. reuteri, L. casei, L. plantarum, and others) names are shown separately by country. Product availability, strengths, and supply rules can change; combination products are not included here.

Priority countries

United States

  • Sold under many different dietary-supplement brand names (no single universal brand) (1) (2)current regulatory framework confirmed · varies by product/CFU count · Not applicable -- dietary supplement category, no single manufacturer

United Kingdom

  • Sold under many different food-supplement brand names (no single universal brand) (4)current regulatory framework confirmed · varies by product/CFU count · Not applicable -- food supplement category, no single manufacturer

Canada

  • Sold under many different Natural Health Product (NPN-licensed) brand names (no single universal brand) (7)current regulatory framework confirmed · varies by product/CFU count; strain-specific claims apply only to L. rhamnosus GG and L. johnsonii La1 · Not applicable -- each licensed NHP has its own NPN and manufacturer

Australia

  • METAGENICS ULTRAFLORA LGG PROBIOTIC (illustrative real example) (9)current artg listed example · Lactobacillus rhamnosus · Metagenics (per ARTG 485570, listed 2025-04-09)
  • Multi-strain probiotic (illustrative real example, JSHealth Vitamins) (9)current artg listed example · L. casei, L. paracasei, L. plantarum, L. rhamnosus · JSHealth Vitamins (per ARTG 402179, listed 2023-01-13)

New Zealand

  • Sold under many different dietary-supplement brand names (no single universal brand) (10)current regulatory framework confirmed · varies by product/CFU count · Not applicable -- dietary supplement category, no single manufacturer
View brands in additional countries.

European Union

Sold under many different food-supplement brand names (no single universal brand) (5) (6)

This page provides general reference information about Lactobacillus as a dietary/food supplement ingredient (or, in Canada, a licensed Natural Health Product) and is not medical advice, a treatment recommendation, or a substitute for guidance from a qualified healthcare provider or dietitian, especially if you are immunocompromised, critically ill, have a central venous catheter, are pregnant or breastfeeding, or are considering it alongside a prescribed antibiotic.

Related medicines

Related conditions